Skip to content

Posts about Medications

Ketamine

Ongoing research is investigating the long-term efficacy and safety of the anesthetic drug ketamine, which studies have shown can rapidly lift depressive symptoms; Dr. Insel talks about the status of ketamine in his blog.

Continue Reading…

Antipsychotics: Taking the Long View

Antipsychotics help people through the crisis of acute psychosis, but the long-term management of chronic mental illness is another matter. It appears that what we currently call “schizophrenia” may comprise disorders with quite different trajectories. For some people, remaining on medication long-term might impede a full return to wellness. For others, discontinuing medication can be disastrous.

Continue Reading…

Experimental Medicine

Dr. Insel discusses the crisis of medication development for mental disorders.

Continue Reading…

Balancing Immediate Needs with Future Innovation

Dr. Insel responds to discussion from the National Advisory Mental Health Council concerning the need to balance research funding for basic science and mental health services.

Continue Reading…

Treatment Development: Where do we go from here?

Dr. Insel discusses opportunities for treatment development.

Continue Reading…

NIMH’s Top 10 Research Advances of 2011

Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.

Continue Reading…

Treatment Development: Where do we go from here?

Dr. Insel discusses opportunities for treatment development.

Continue Reading…

Treatment Development: The Past 50 Years

Dr. Insel discusses the state of psychiatric research and development (R&D) in the public and private sectors

Continue Reading…

Antidepressants: A complicated picture

Dr. Insel discusses the complicated nature of research on the efficacy antidepressants.

Continue Reading…

NIMH’s Top 10 Research Events and Advances of 2010

10 breakthroughs and events of 2010 which are changing the way we approach mental disorders.

Continue Reading…

Wanted: A Few Good Assays

NIMH/NIH is nurturing medications development via assays that probe new molecular targets relevant to mental disorders.

Continue Reading…